Back to Journals » Cancer Management and Research » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,685 | Dovepress* | 9,851+ | 1,240 | 11,091 | |
PubMed Central* | 834 | 243 | 1,077 | ||
Totals | 10,685 | 1,483 | 12,168 | ||
*Since 19 May 2017 |
View citations on PubMed Central and Google Scholar